People living in the United States must travel significantly farther to access methadone treatment for opioid addiction than Canadians, suggests a new study led by Assistant Professor Ofer Amram, PhD.
Read the WSU Insider piece here.
Comparison with Canada highlights poor access to U.S. methadone treatment
